EUVIMEDEUVIMED entdecken
Crossref

Thrombosis and infections associated with PICC in onco-hematological patients, what is their relevance?

Manuel Sánchez Cánovas, Esmeralda García Torralba, Noel Blaya Boluda, Ana Sánchez Saura, Gabriel Puche Palao, Ana Sánchez Fuentes, Lorena Martínez Montesinos, Carmen Poveda Ganga, Lucía García Tomas, Josefa Bayona Jiménez, Ángeles Cos Zapata, Carmen María Muñoz Jurado und 4 weitere

Clinical and Translational Oncology · 2024

DOI: 10.1007/s12094-024-03548-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Manuel Sánchez Cánovas und 15 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, IMIB, Hospital Universitario Morales Meseguer, Universidad de Murcia, Murcia, Spain. manuelsanchezcanovas@gmail.com. Hauptthemen laut MEDLINE: Thrombosis, Catheter-Related Infections, Catheterization, Peripheral. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Peripherally inserted central venous catheters (PICC) in the onco-hematological patients may be associated with thrombosis or infections that may have short- to medium-term repercussions. MATERIAL AND METHODS: Single-centre retrospective analysis of a prospectively collected cohort. Primary objective was to establish the PICC-thrombosis and infections incidence. Secondary objectives were to analyze profile of patients suffering from these complications and variables associated with an increased likelihood of developing these events. RESULTS: 549 patients were recruited. 58.5% (n = 321) were oncology patients and 41.5% (n = 228) hematology patients. The incidence of PICC-associated thrombosis was 3.5% (n = 19). Thrombosis was associated with progression of the underlying malignant pathology in 10.6% (n = 2) of cases. No association was found between clinical variables analysed and development of thrombosis. Incidence of PICC-associated infections was 7.65% (n = 42). In the 30 days prior to PICC infection, 57.1% (n = 24) had a febrile syndrome of another focus, 73.8% (n = 11) had been hospitalized, 49.5% (n = 25) had a neutrophil count of 0-500 cells/mm3 and 47.6% (n = 20) had an episode of neutropenic fever. Variables significantly associated with the development of infection were hematological patients, high-flow PICC, 3-lm PICC or PICC insertion because of administration of vesicant therapy. CONCLUSIONS: Incidence of PICC-associated thrombosis is low and apparently less prognostically aggressive than other forms of thrombosis associated with cancer, without identify predictive factors. Infection was more prevalent and the identification of risk factors in our series could facilitate its prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombosisCatheter-Related InfectionsCatheterization, PeripheralHumansFemaleMaleRetrospective StudiesMiddle AgedAgedIncidenceAdultNeoplasmsCatheterization, Central VenousCentral Venous CathetersHematologic NeoplasmsAged, 80 and overYoung AdultAdolescent

Stichwörter der Autor:innen

Hematological patientsOncological patientsPICC-associated infectionsPICC-associated thrombosisPeripherally inserted central venous catheters

Autor:innen und Institutionen

  • Medical Oncology Department, IMIB, Hospital Universitario Morales Meseguer, Universidad de Murcia, Murcia, Spain. manuelsanchezcanovas@gmail.com.
  • Medical Oncology Department, IMIB, Hospital Universitario Morales Meseguer, Universidad de Murcia, Murcia, Spain.
  • Medical Oncology Department, Hospital Clínico Universitario Virgen de La Arrixaca, El Palmar, Spain.
  • Internal Medicine Department, Hospital G. Universitario Reina Sofía, Murcia, Spain.
  • Hematology Department, IMIB, Morales Meseguer General University Hospital, University of Murcia, Murcia, Spain.
  • Onco-Hematological Day Hospital Unit, IMIB, Hospital Universitario Morales Meseguer, Universidad de Murcia, Murcia, Spain.

Zitieren

APA

Sánchez Cánovas, M., García Torralba, E., Blaya Boluda, N., Sánchez Saura, A., Puche Palao, G., Sánchez Fuentes, A., Martínez Montesinos, L., Poveda Ganga, C., García Tomas, L., Bayona Jiménez, J., Cos Zapata, Á., Muñoz Jurado, C. M., Pina Mingorance, I., Caravaca Hernández, M. A., Vicente García, V., & Ayala de la Peña, F. (2024). Thrombosis and infections associated with PICC in onco-hematological patients, what is their relevance?. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03548-8

Vancouver

Sánchez Cánovas M, García Torralba E, Blaya Boluda N, Sánchez Saura A, Puche Palao G, Sánchez Fuentes A, et al. Thrombosis and infections associated with PICC in onco-hematological patients, what is their relevance?. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03548-8

BibTeX
@article{SnchezCnovas2024,
  author = {Sánchez Cánovas, Manuel and García Torralba, Esmeralda and Blaya Boluda, Noel and Sánchez Saura, Ana and Puche Palao, Gabriel and Sánchez Fuentes, Ana and Martínez Montesinos, Lorena and Poveda Ganga, Carmen and García Tomas, Lucía and Bayona Jiménez, Josefa and Cos Zapata, Ángeles and Muñoz Jurado, Carmen María and Pina Mingorance, Inmaculada and Caravaca Hernández, María Amor and Vicente García, Vicente and Ayala de la Peña, Francisco},
  title = {Thrombosis and infections associated with PICC in onco-hematological patients, what is their relevance?},
  journal = {Clinical and Translational Oncology},
  year = {2024},
  doi = {10.1007/s12094-024-03548-8}
}
Kostenlos starten →